Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dihydropteroate synthase (DHPS) is a key enzyme in the folate biosynthesis pathway of *Plasmodium falciparum*, the parasite responsible for the most severe form of human malaria. DHPS catalyzes the condensation of para-aminobenzoic acid (pABA) with dihydropterin pyrophosphate to produce dihydropteroate, a precursor for folic acid derivatives essential for DNA synthesis and cell division in the parasite. It is a target for sulfa drugs like sulfadoxine. Resistance to these drugs arises from point mutations within the dhps gene that reduce drug binding affinity without abolishing enzymatic function.
Competitive inhibition at pABA site
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dihydropteroate Synthase (Plasmodium falciparum) (DHPS).